Latest filing published 23 Feb 2015 for Kiora Pharmaceuticals INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -53.8%Entry US$32,400.00 · Close at T+365 US$14,963.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
(innoven Partenaires S.A.) Ipsa: trading record in brief
(innoven Partenaires S.A.) Ipsa appears in our data through filings on Kiora Pharmaceuticals Inc shares, published by SEC (Form 4). Altogether 5 filings, all relating to 19 February 2015.
Purchases make up the whole of the open-market record (1 purchase, €1.9M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 23 February 2015, the filings show a transaction in Kiora Pharmaceuticals Inc. The most recent open-market purchase was published on 23 February 2015, 4,277 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to (innoven Partenaires S.A.) Ipsa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 524,998 sharesCommon StockSEC:0001144204-15-011489:0
- 138,194 shares@ US$4.20Common StockSEC:0001144204-15-011489:3
- 366,667 shares@ US$6.00Common StockSEC:0001144204-15-011489:4Canonical exit: 20 May 2015 (T+90)
- 169,306 sharesCommon StockSEC:0001144204-15-011489:1
- 261,314 sharesCommon StockSEC:0001144204-15-011489:2
5 of 5 declarations